# EDGAR Filing Document

**Accession Number:** 0001378325
**File Stem:** 0001193125-25-157632
**Filing Date:** 2025-7
**Character Count:** 27479
**Document Hash:** 104d9afb401ed821765f6aab7948ca60
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-157632.hdr.sgml**: 20250710

**ACCESSION NUMBER**: 0001193125-25-157632

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20250710

**DATE AS OF CHANGE**: 20250710

**EFFECTIVENESS DATE**: 20250710

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CapsoVision, Inc
- **CENTRAL INDEX KEY:** 0001378325
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 203369494
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-288615
- **FILM NUMBER:** 251116702

**BUSINESS ADDRESS:**
- **STREET 1:** 18805 COX AVENUE SUITE 250
- **CITY:** SARATOGA
- **STATE:** CA
- **ZIP:** 95070
- **BUSINESS PHONE:** (408) 370-4790

**MAIL ADDRESS:**
- **STREET 1:** 18805 COX AVENUE SUITE 250
- **CITY:** SARATOGA
- **STATE:** CA
- **ZIP:** 95070

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Capso Vision Inc
- **DATE OF NAME CHANGE:** 20061016

**As filed with the Securities and Exchange Commission on July 10, 2025** 

**Registration No.<u> </u>** 

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM S-8** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

## CapsoVision, Inc.
**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| **Delaware** | **20-3369494** |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

**18805 Cox Avenue, Suite 250** 

**Saratoga, CA 95070** 

**(Address, including zip code, of Principal Executive Offices)** 

**CapsoVision, Inc. 2025 Performance Incentive Plan** 

**CapsoVision, Inc. Amended and Restated 2005 Stock Plan** 

**(Full title of the plan)** 

**Kang-Huai (Johnny) Wang** 

**President and Chief Executive Officer** 

**18805 Cox Avenue, Suite 250** 

**Saratoga, CA 95070** 

**+1-408-624-1488** 

**(Name, address and telephone number, including area code, of agent for service)** 

***COPIES TO:***

---

| | |
|:---|:---|
| **Portia Ku, Esq.**<br> **O'Melveny & Myers LLP**<br> **JC Plaza, 12th Floor**<br> **1225 Nanjing Road West**<br> **Shanghai 200040**<br> **+86-21-2307-7000**  | **Kurt Berney, Esq.**<br> **O'Melveny & Myers LLP**<br> **Two Embarcadero Center,**<br> **28th Floor**<br> **San Francisco, California 94111**<br> **+1-415-984-8700** |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**PART I** 

INFORMATION REQUIRED IN THE

SECTION 10(a) PROSPECTUS

The document(s) containing the information specified in Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) promulgated under the Securities Act of 1933, as amended (the "Securities Act").

------

**PART II** 

INFORMATION REQUIRED IN THE

REGISTRATION STATEMENT

**Item 3.** **Incorporation of Certain Documents by Reference** <br>

The following documents of CapsoVision, Inc. (the "Company" or "Registrant") filed with the Securities and Exchange Commission (the "Commission") are incorporated herein by reference:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company's Prospectus, dated [July 2, 2025](http://www.sec.gov/Archives/edgar/data/1378325/000119312525155088/d916440d424b4.htm) , filed pursuant to Rule 424(b) under the Securities Act in connection with its Registration Statement on Form S-1 (Commission File No. 333-287148) initially filed with the Commission on [May 9, 2025](http://www.sec.gov/Archives/edgar/data/1378325/000119312525116894/d916440ds1.htm) , as amended, which includes unaudited financial statements for the three months ended and as of
March 31, 2025 and audited financial statements for the years ended and as of December 31, 2023 and 2024.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The description of the Company's Common Stock contained in its Registration Statement on Form 8-A filed with the Commission on [June 13, 2025](http://www.sec.gov/Archives/edgar/data/1378325/000119312525140839/d67263d8a12b.htm) (Commission File No. 001-42705), and any other amendment or report filed for the purpose of updating such description.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) The Company's Current Report on Form 8-K filed with the Commission on [July 3, 2025](http://www.sec.gov/Archives/edgar/data/../../../ix?doc=/Archives/edgar/data/1378325/000119312525155527/d55184d8k.htm) (Commission File No. 001-42705).

All documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with Commission rules shall not be deemed incorporated by reference into this Registration Statement. Any statement contained herein or in a document, all or a portion of which is incorporated or deemed to be incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or amended, to constitute a part of this Registration Statement.

**Item 4.** **Description of Securities** <br>

Not applicable.

**Item 5.** **Interests of Named Experts and Counsel** <br>

Not applicable.

------

**Item 6.** **Indemnification of Directors and Officers** <br>

Pursuant to Section 145 of the Delaware General Corporation Law (the "DGCL"), a corporation shall have the power to indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than a derivative action by or in the right of such corporation) by reason of the fact that such person is or was a director, officer, employee or agent of such corporation, or serving at the request of such corporation in such capacity for another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding, if such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of such corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.

The DGCL also permits indemnification by a corporation under similar circumstances for expenses (including attorneys' fees) actually and reasonably incurred by such persons in connection with the defense or settlement of a derivative action or suit, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to such corporation unless the Delaware Court of Chancery or the court in which such action or suit was brought shall determine upon application that such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper.

To the extent a present or former director or officer is successful in the defense of such an action, suit or proceeding referenced above, or in defense of any claim, issue or matter therein, a corporation is required by the DGCL to indemnify such person for actual and reasonable expenses incurred in connection therewith. Expenses (including attorneys' fees) incurred by such persons in defending any action, suit or proceeding may be paid in advance of the final disposition of such action, suit or proceeding upon in the case of a current officer or director, receipt of an undertaking by or on behalf of such person to repay such amount if it is ultimately determined that such person is not entitled to be so indemnified.

The DGCL provides that the indemnification described above shall not be deemed exclusive of other indemnification that may be granted by a corporation pursuant to its bylaws, disinterested directors' vote, stockholders' vote and agreement or otherwise.

Section 102(b)(7) of the DGCL enables a corporation, in its certificate of incorporation or an amendment thereto, to eliminate or limit the personal liability of a director to the corporation or its stockholders for monetary damages for violations of the directors' fiduciary duty, except (i) for any breach of the director's duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) pursuant to Section 174 of the DGCL (providing for liability of directors for unlawful payment of dividends or unlawful stock purchases or redemptions) or (iv) for any transaction from which a director derived an improper personal benefit. The Registrant's certificate of incorporation provides for such limitations on liability for its directors.

------

The DGCL also provides corporations with the power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of such corporation, or is or was serving at the request of such corporation in a similar capacity for another corporation, partnership, joint venture, trust or other enterprise, against any liability asserted against him or her in any such capacity or arising out of his or her status as such, whether or not the corporation would have the power to indemnify him or her against such liability as described above. In connection with this offering, the registrant will obtain liability insurance for its directors and officers. Such insurance would be available to its directors and officers in accordance with its terms.

The Registrant's certificate of incorporation requires the Registrant to indemnify and hold harmless, to the fullest extent permitted by applicable law as it presently exists or may hereafter be amended, any person (a "covered person") who was or is made or is threatened to be made a party or is otherwise involved in any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (a "proceeding") by reason of the fact that he or she is or was a director, officer or member of a committee, or, while a director or officer, is or was serving at the Registrant's request as a director or officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise or non-profit entity, including service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys' fees), judgment, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with a proceeding.

In addition, under the Registrant's certificate of incorporation, in certain circumstances, the Registrant is required to pay the expenses (including attorneys' fees) incurred by a covered person in defending a proceeding in advance of the final disposition of such proceeding; provided, however, that the Registrant is not required to advance any expenses to a person against whom the Registrant directly brings an action, suit or proceeding alleging that such person (1) committed an act or omission not in good faith or (2) committed an act of intentional misconduct or a knowing violation of law. Additionally, an advancement of expenses incurred by a covered person shall be made only upon delivery to the Registrant of an undertaking, by or on behalf of such covered person, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal or otherwise in accordance with Delaware law that such covered person is not entitled to be indemnified for such expenses.

In addition, the Registrant plans to enter into indemnification agreements with the Registrant's directors and executive officers that provide for additional indemnification protections, which form of agreement has been filed as an exhibit to the Registrant's registration statement on Form S-1 referred to in Item 3 above.

**Item 7.** **Exemption from Registration Claimed** <br>

Not applicable.

**Item 8.** **Exhibits** <br>

See the attached Exhibit Index at page 8, which is incorporated herein by reference.

------

**Item 9.** **Undertakings** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The undersigned Registrant hereby undertakes:

(1)To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

(i)To include any prospectus required by Section 10(a)(3) of the Securities Act;

(ii)To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement;

(iii)To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement;

*provided, however,* that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

(2)That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial *bona fide* offering thereof.

(3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial *bona fide* offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the provisions described in Item 6 above, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

------

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| Exhibit<br>Number | Description of Exhibit |
| 4.1 | [CapsoVision, Inc. 2025 Equity Incentive Plan. (Incorporated by reference to Exhibit 10.09 to the Company's Registration Statement on Form S-1 (Commission File No. 333-287148) initially filed with the Commission on May 9, 2025, as amended.)](http://www.sec.gov/Archives/edgar/data/1378325/000119312525149285/d916440dex1009.htm) |
| 4.2 | [CapsoVision, Inc. Amended and Restated 2005 Stock Plan. (Incorporated by reference to Exhibit 10.07 to the Company's Registration Statement on Form S-1 (Commission File No. 333-287148) initially filed with the Commission on May 9, 2025, as amended.)](http://www.sec.gov/Archives/edgar/data/1378325/000119312525116894/d916440dex1007.htm) |
| 5 | [Opinion of O'Melveny & Myers LLP (opinion re legality).](d49885dex5.htm) |
| 23.1 | [Consent of Baker Tilly US, LLP (consent of independent registered public accounting firm).](d49885dex231.htm) |
| 23.2 | [Consent of Counsel (included in Exhibit 5).](d49885dex5.htm) |
| 24 | [Power of Attorney (included in this Registration Statement under "Signatures").](#sig) |
| 107 | [Filing Fee Table](d49885dexfilingfees.htm) |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Form S-8 Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Saratoga, State of California, on July 10, 2025.

---

| | |
|:---|:---|
| **CAPSOVISION, INC.** | **CAPSOVISION, INC.** |
| By: | /s/ Kang-Huai (Johnny) Wang |
|  | Kang-Huai (Johnny) Wang |
|  | President and Chief Executive Officer |

---

**POWER OF ATTORNEY** 

Each person whose signature appears below constitutes and appoints Kang-Huai (Johnny) Wang as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments, exhibits thereto and other documents in connection therewith) to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| Signature | Title | Date |
| /s/ Kang-Huai (Johnny) Wang<br> Kang-Huai (Johnny) Wang | Director, President and Chief Executive Officer<br> (Principal Executive Officer) | July 10, 2025 |
| /s/ Kevin Lundquist<br> Kevin Lundquist | Chief Financial Officer (Principal Financial and Accounting Officer) | July 10, 2025 |
| /s/ Chen Lung Tsai<br> Chen Lung Tsai | Director | July 10, 2025 |
| /s/ Hui Ying (Patty) Kuo<br> Hui Ying (Patty) Kuo | Director | July 10, 2025 |
| /s/ Julia Gouw<br> Julia Gouw | Director | July 10, 2025 |
| /s/ Michele Harari<br> Michele Harari | Director | July 10, 2025 |
| /s/ Joanne Imperial, M.D.<br> Joanne Imperial, M.D. | Director | July 10, 2025 |
| /s/ Wen-Herng Henry King<br> Wen-Herng Henry King | Director | July 10, 2025 |

---

## Ex-5

EXHIBIT 5

**[OMM Letterhead]** 

July 10, 2025

CapsoVision, Inc.

18805 Cox Avenue, Suite 250

Saratoga, CA 95070

---

| | |
|:---|:---|
| Re: | ***Registration of Securities of CapsoVision, Inc.***  |

---

Ladies and Gentlemen:

In connection with the registration of up to 6,248,074 shares of Common Stock of CapsoVision, Inc., a Delaware corporation (the "Company"), par value $0.001 per share (the "Shares"), under the Securities Act of 1933, as amended, pursuant to a Registration Statement on Form S-8 (the "Registration Statement"), filed with the Securities and Exchange Commission on or about the date hereof, 4,204,204 of such Shares to be issued or delivered pursuant to the CapsoVision, Inc. 2025 Equity Incentive Plan and 2,043,870 of such Shares to be issued or delivered pursuant to the CapsoVision, Inc. Amended and Restated 2005 Stock Plan (the "Plans"), you have requested our opinion set forth below.

In our capacity as counsel, we have examined originals or copies of those corporate and other records of the Company we considered appropriate.

On the basis of such examination and our consideration of those questions of law we considered relevant, and subject to the limitations and qualifications in this opinion, we are of the opinion that the Shares have been duly authorized by all necessary corporate action on the part of the Company and, when issued in accordance with such authorization, the provisions of the applicable Plan and relevant agreements duly authorized by and in accordance with the terms of that Plan, and upon payment for and delivery of the Shares as contemplated in accordance with the applicable Plan, and either (a) the countersigning of the certificate or certificates representing the Shares by a duly authorized signatory of the registrar for the Company's Common Stock, or (b) the book-entry of the Shares by the transfer agent for the Company's Common Stock in the name of The Depository Trust Company or its nominee, the Shares will be validly issued, fully paid and non-assessable.

We consent to your filing this opinion as an exhibit to the Registration Statement.

---

| |
|:---|
| Respectfully submitted, |
| /s/O'Melveny & Myers LLP |

---

## Exhibit 23.1

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in this Registration Statement on Form S-8 of CapsoVision, Inc. (the "Company") of our report dated April 1, 2025 (July 2, 2025 as to the effects of the reverse stock split described in Note 3), which report expresses an unqualified opinion and includes an explanatory paragraph relating to the Company's ability to continue as a going concern, relating to the financial statements of the Company, which appears in the Prospectus dated July 2, 2025.

---

| |
|:---|
| /s/ BAKER TILLY US, LLP |
| Santa Clara, California |
| July 10, 2025 |

---

## Ex-Filing

**EXHIBIT 107** 

**CALCULATION OF FILING FEE TABLE** 

**<u>Form S-8</u>**

(Form Type)

**CapsoVision, Inc.** 

(Exact Name of Registrant as Specified in its Charter)

**Table 1: Newly Registered Securities** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;Security Type | Security<br> Class<br> Title | Fee<br>Calculation<br>Rule | Amount<br>Registered(1) | Proposed<br>Maximum<br>Offering<br>Price Per<br>Unit(2) | Maximum<br>Aggregate<br>Offering Price(2) | Fee<br> Rate | Amount of<br>Registration<br>Fee |
| &nbsp;&nbsp;&nbsp;Equity | Common Stock, par value of $0.001 per share, issuable pursuant to the Registrant's 2025 Equity Incentive Plan | Other(3) | 4204204 | $4.30 | $18078077 | 0.0001531 | $2768 |
| &nbsp;&nbsp;&nbsp;Equity | Common Stock, par value of $0.001 per share, issuable pursuant to the Registrant's Amended and Restated 2005 Stock Plan | Other(3) | 2043870 | $0.68 | $1389832 | 0.0001531 | $213 |
| &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts |  | $19467909 |  | $2981 |
| &nbsp;&nbsp;&nbsp;Total Fee Offsets | &nbsp;&nbsp;&nbsp;Total Fee Offsets | &nbsp;&nbsp;&nbsp;Total Fee Offsets | &nbsp;&nbsp;&nbsp;Total Fee Offsets |  |  |  | $0 |
| &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due |  |  |  | $2981 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) This Registration Statement covers, in addition to the number of shares of CapsoVision, Inc., a Delaware corporation (the "Company" or the "Registrant"), common stock, par value $0.001 per share (the "Common Stock"), stated above, options and other rights to purchase or acquire the shares of Common Stock covered by this Registration Statement and, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), an additional indeterminate number of shares, options and rights that may be offered or issued pursuant to the CapsoVision, Inc. 2025 Equity Incentive Plan (the "2025 Plan") and the CapsoVision, Inc. Amended and Restated 2005 Stock Plan (the "2005 Plan" and together with the 2025 Plan, the "Plans") as a result of one or more adjustments under the Plans to prevent dilution resulting from one or more stock splits, stock dividends or similar transactions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Estimated solely for the purpose of calculating the amount of the registration fee. The offering price per share and the aggregate offering price for the shares issuable pursuant to the 2025 Plan are based upon the average of the high and low prices of the Registrant's common stock as reported on the Nasdaq Stock Market on July 7, 2025, in accordance with Rule 457(c) of the Securities Act, and for the shares issuable pursuant to the 2005 Plan are based upon the weighted-average exercise price of the outstanding options under that Plan, in accordance with Rule 457(h) of the Securities Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) The registration fee has been calculated in accordance with Rule 457(h) and Rule 457(c) promulgated under the Securities Act.